DNLI Competitors & Alternatives
Compare Denali Therapeutics Inc with similar stocks in the same industry
Biotechnology
DNLI
Main Stock$20.00
Tradestie Score
65
Market Cap
$2.18B
Revenue Growth
-1.0%
Analyst Upside
+80.3%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LGND
Ligand Pharmaceuticals Inc.
|
$302.96
|
$3.49B | 32.1 | 44 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$10.55
|
$3.40B | 107.2 | 39 | Compare |
|
QURE
uniQure N.V.
|
$23.46
|
$3.39B | - | 48 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$46.81
|
$3.33B | - | 68 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$23.20
|
$3.31B | - | 53 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 48 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$23.63
|
$3.09B | - | 47 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$29.94
|
$3.08B | - | 57 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
|
$3.03B | - | 48 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$38.02
|
$3.02B | - | 60 | Compare |
More DNLI Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2836)
228 stocks in this industry